.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Prof. Dr. Asisa Volz

Hannover/ DE

University of Veterinary Medicine Hannover

Vorsitz

26.09.2023
14:30 – 16:00
Scientific symposium
Tropical and Emerging Infections
Lecture hall

Weitere Beteiligungen

25.09.2023
Poster
P-1-100
Generation of a pan-genotypic MVA vector for targeting chronic hepatitis B via therapeutic vaccination
Chronic Infections
26.09.2023
Poster
P-2-55
Generation and in vitro characterization of two recombinant MVA candidate vaccines expressing Marburg virus glycoprotein or nucleoprotein
Tropical and Emerging Infections
26.09.2023
Poster
P-2-58
A soluble version of Nipah virus glycoprotein G delivered by vaccinia virus MVA activates specific CD8 and CD4 T cells in mice
Tropical and Emerging Infections
26.09.2023
Poster
P-2-72
Establishment of a multiplex digital PCR to detect MVA-based vaccines in human plasma
Immune Prevention and Therapy
26.09.2023
Poster
P-2-74
Development of a preclinical model for human mpox disease using skin scarification in CAST/Eij
Tropical and Emerging Infections
26.09.2023
Poster
P-2-85
Development of a live-attenuated monkeypox virus for use in improved diagnostics
Tropical and Emerging Infections
26.09.2023
Poster
P-2-104
Mpox: evaluation of immune responses induced after infection versus vaccination
Tropical and Emerging Infections
26.09.2023
Poster
P-2-105
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike induce differential S1- and S2-specific immune responses in humans
Tropical and Emerging Infections
26.09.2023
15:30 – 15:40 8 Min. 2 Min.
Short Talk
S-6-4
The vaccine candidate MVA-MERS-S against Middle East Respiratory Syndrome Coronavirus: safety and immunogenicity results from a randomized-controlled Phase Ib trial
Tropical and Emerging Infections